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The purpose of this study was to assess the knowledge of Irish consumers regarding 
antibiotic use in Ireland. Data was obtained on antibiotic use, frequency, associated source 
and general awareness regarding antibiotics and antibiotic resistance. 
 
A cross-sectional survey was designed to analyse consumer’s perception and knowledge 
of antibiotic and antibiotic resistance. A total of 763 completed questionnaires were 
collected. The questionnaire was targeted for general public, based in Ireland. 
 
Fifty-seven percent of respondents are trying to completely avoid antibiotics, unless 
absolutely necessary. Half of respondents (50%) took antibiotics in the last 12 months. 
The majority of respondents obtained antibiotics through a valid medical prescription. A 
prevalence of 6% of self-medication with antibiotic mainly leftovers from previous 
course was reported. Almost 80% of the respondents discontinue the antibiotic treatment 
when all antibiotics have been taken as directed. Gaps in population understanding of 
antibiotics were observed. Only 47% of the respondents knew that antibiotics were not 
effective against viruses. Eighty-two percent of respondents understood that unnecessary 
use of antibiotics make them ineffective. Almost sixteen percent had never heard of the 
term Antibiotic Resistance. Almost all the respondents stated that the availability of 
public awareness campaigns is poor. The majority of respondents (70%), noted that they 
would trust social media to inform them about antibiotic resistance. 
 
It is important to note that there are some notable socio-demographic differences in 
relation to the frequency of antibiotic intake. Furthermore, this study suggests that an 
increase in educational degrees is correlated with the level of awareness. 
Although the study shows a certain level of understanding of the antimicrobial resistance 
problem, there still is a lack of knowledge, mostly reported by consumers with a lower 
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Infections are very common and are responsible for a large number of diseases affecting 
human health. Infectious diseases are caused by pathogenic microorganisms, such as 
bacteria, viruses, parasites or fungi; the diseases can be spread, directly or indirectly, from 
one person to another. Zoonotic diseases are infectious diseases of animals that can cause 
disease when transmitted to humans. (Anon., n.d.) 
Infections caused by bacteria can be prevented, managed and treated through anti-
bacterial group of compounds known as antibiotics. 
 
Sir Alexander Fleming, a Scottish biologist laid the foundations for modern antibiotics 
with his discoveries of enzyme lysozyme in (1923) and the antibiotic substance penicillin 
in 1928. 
It was in 1928 when Sir Alexander Fleming observed interesting zones of clearing 
(inhibition) on a bacterial agar plate around a common fungus. This fungus was identified 
as Penicillium notatum  which had an antibacterial effect on a strain of Staphylococcus. 
The active substance was effective even when diluted up to 100 times.  
 
Later he would say,  
“I certainly didn’t plan to revolutionize all medicine by discovering the world’s first 
antibiotic, or bacteria killer. But I suppose that was exactly what I did”. (Tan, 2015) 
 
Penicillin made a difference during the first half of the 20th century. The first patient was 
successfully treated for streptococcal septicemia in the United States in 1942. However, 
supply was limited and demand was high in the early days of penicillin. 
Penicillin helped reduce the number of deaths and amputations of troops during World 
War II. According to records, there were only 400 million units of penicillin available 
during the first five months of 1943; by the time World War II ended, U.S. companies 




In a 1945 interview with The New York Times, Alexander Fleming, who won a Nobel 
Prize that year for his discovery of penicillin, warned that misuse of the drug could result 
in selection for resistant bacteria. True to this prediction, resistance began to emerge 
within 10 years of the wide scale introduction of penicillin. Indeed, although antibiotics 
have transformed the medical response to bacterial illness and rendered easily treatable 
many formerly deadly infections, the mishandling and misprescription of these drugs 
have transformed the bacterial population such that many antibiotics have partially or 
entirely lost their efficacy. (Rosenblatt-Farrell, 2009)  
 
The emerging problem of antibiotic resistance has become widely known because of the 
emergence of methicillin-resistant Staphylococcus Aureus (MRSA), an increasingly 
common bacterial agent with major consequences, identified in the UK in 1962 and in 
the US in 1968. (Ventola, 2015) 
 
Antimicrobial resistance is reported to affect multiple sectors, especially human health, 
animal health and agriculture. It requires a collaborative global approach across sectors 
to detect, prevent, and respond to these threats when they occur. (Anon., 2018) 
 
Over a course of studies, it was discovered that inappropriate use of antimicrobial drugs 
is closely related to the knowledge, attitudes and behavior of the population. Healthcare 
professional’s behavior towards prescribing antibiotic is also a contributing factor.  
Improvement of the rational use of antibiotics is encouraged by the World Health 
Organization through prescription-only use of antibiotics and through educational 
measures. (Topor, 2017) 
 
As studies show that the overuse and misuse of antibiotics is closely related to attitudes 
and behavior of the population, as well as the antibiotic prescribing behavior of the 
healthcare professionals, this study will evaluate consumer perception towards the use of 










1.2 Classification of Antibiotics 
 
Mechanism of action Antibiotic class Examples 
Inhibition of cell wall synthesis 








Penicillin G, methicillin, ampicillin 
Cephalexin, cefacor, ceftriaxone  
















Inhibition of DNA synthesis 
Major groups topoisomerase 
inhibitors (Floroquinolones) 
Quinolones 1st Generation: Flumequine, 
Nalidixic Acid, Oxolinic Acid, 
Pipermidic Acid 
2nd Generation: Ciprofloxacin, 
Oflixacin, Norfloxacin, Perfloxacin 
3rd Generation: Levofloxacin, 
Sparfloxacin 
4th Generation: Moxifloxacin, 
Gatifloxacin, Difloxacin, 
Enrofloxacin, Marbofloxacin 
Inhibition of RNA synthesis Rifamycins Rifampicin 








Mycolic acid synthesis inhibitor Isoniazid Isoniazid 
Other mechanisms Metronidazole Metronidazole, secnidazole, 
tinidazole 










                 Figure.1 Chemical structure of a beta-lactam ring (Tidwell, 2008) 
 
 
Members of this class of antibiotics contain a 3-carbon and 1-nitrogen ring that is highly 
reactive. They interfere with proteins essential for synthesis of bacterial cell wall, and in 
the process either kills or inhibits their growth. Certain bacterial enzymes termed 
penicillin-binding protein (PBP) are responsible for cross linking peptide units during 
synthesis of peptidoglycan. Members of beta-lactam antibiotics are able to bind 
themselves to these PBP enzymes, and in the process, they interfere with the synthesis of 
peptidoglycan resulting in lysis and cell death. The most prominent representatives of the 
beta-lactam class include Penicillins, Cephalosporines, Monobactams and Carbapenems. 
(Etebu et al., 2016) 
 
1.2.2 Penicillins    
Penicillins are involved in a class of diverse group of compounds, most of which end in 
the suffix –cillin. They are beta-lactams compounds containing a nucleus of 6-
aminopenicillanic acid (lactam plus thiazolidine) ring and other ring side chains. (Etebu 
et al., 2016)  
Certain bacteria are able to counter the activity of antibiotics by encoding enzymes. 
Antibiotics such as ampicillin, carbenicillin and amoxicillin have been developed semi-
synthetically with different side-chains. 
These side chains confer on the antibiotics the ability to evade the degradative capacity 
of certain enzymes produces by certain bacterial strains as well as facilitating the 
movement of antibiotics across the outer membrane of bacterial cell walls. This double-
pronged capacity increases their spectrum of activity against Gram-negative bacteria. 
Some penicillins, such as Augmentin are produced in combination with a non-antibiotic 
compound that are able to inhibit the activity of bacterial penicillinase enzyme. Therefore, 
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the combination between an antibiotic and a non-antibiotic compound can prolong the 
antibacterial activity. (Poirel et at., 2005) 
 
1.2.3 Cephalosporin 
Members of this group of antibiotics are similar to penicillin in their structure and mode 
of action. They form part of the most commonly prescribed antibiotics. (Scholar, 2007) 
Cephalosporins contain 7-aminocephalosporanic acid nucleus and side-chain containing 
3, 6-dihydri-2 H-1, 3-thiazane rings. Cephalosporins are used in the treatment of bacterial 
infections and diseases arising from Penicillinase-producing, Methicillin-susceptible 
Staphylococci and Streptococci, Proteus mirabilis, some Escherichia coli, Klebsiella 
pneumonia, Haemophilus influenza, Enterobacter aerogenes and some Neisseria. (Healy, 
2008) 
They are subdivided intro generations 1st to 5th: 
 First generation cephalosporins have the highest activity against gram-positive organisms 
and the lowest against gram-negative. 
 Second generation cephalosporins are more active against gram-negative bacteria, with 
less activity against gram-positive. 
 Third generation cephalosporins have a greater spectrum against gram-negative bacteria 
and are more resistant to gram-negative B-lactamase enzymes than first and second 
generation cephalosporins. 
 Fourth generation has an improved gram-positive spectrum while retaining the expanded 
gram-negative activity of the third-generation compounds. (Watson and Bonomo, 2017) 
 Ceftaroline fosamil is a novel fifth-generation parental oxyimino cephalosporin with 




Carbapenem use has increased as a result of the rising resistance to cephalosporin 
antibiotics in Enterobacteriaceae. (Livermore, 2012) These compounds occupy a very 
important place in the fight against bacterial infections. This is because they are able to 
resist the hydrolytic action of beta-lactamase enzyme. Carbapenems possess the broadest 
spectrum of activity and greatest potency against Gram-positive and Gram-negative 





The first antibiotic belonging to this class was first discovered and isolated in 1952. 
Macrolides are characterized by 14-, 15-, 16-membered macrocyclic lactose rings with 
unusual deoxy sugars L-cladinose and D-desosamine attached. They have a wider 
spectrum of antibiotic than Penicillins and are often administrated to patients allergic to 
penicillin. (Moore, 2015). Macrolides tend to build up in the body because the liver is 
able to recycle it into the bile. 
 
1.2.6 Tetracyclines 
Tetracyclines was discovered in 1945 from a soil bacterium of the genus Streptomyces by 
Benjamin Duggar. (Michalova et al, 2004). Members of this class have 4 hydrocarbon 
rings and they are known by name with the suffix –“cycline”.   
Members of this class of antibiotics are grouped into different generations based on the 
method of synthesis. Those obtained by biosynthesis are the 1st generation which includes: 
tetracycline, chlortetecycline, oxytetraxycline and demeclocycline. Second generation 
includes: doxycycline, lymecycline, meclocycline, methacycline, minocycline and 
rolitetracycline which are derivates of semi-synthesis. Third generation are obtained from 
total synthesis, such as Tigecycline. (Etebu et al., 2016)  
Their target of antimicrobial activity in bacteria is the ribosome.  
 
1.2.7 Quinolones 
This class of antibiotic was first discovered as nalidixic acid by scientists involved in 
search of antimalarial drugs. (Tillotson, 1996) Quinolones were derived from quinine. 
(MacGowan, 2003) 
They are able to interfere with DNA replication and transcription in bacteria. Their 
structure generally consists of two rings, but recent generations of quinolones possess an 
added ring structure (fluorine molecule at C6 created the “fluoroquinolones”) which 
enables them to extend their spectrum of antimicrobial activity to some bacteria, 
particularly anaerobic bacteria. (Tillotson, 1996) 
 
1.2.8 Aminoglycosides 
The first drug to be discovered among members of this class was streptomycin, first 
isolated in 1943. (Kalra, 2012). Streptomycin has been greatly used against 
Mycobacterium tuberculosis, the causal agent of tuberculosis among humans. The 




Aminoglycosides have a broad spectrum of antibacterial activity and are effective against 
aerobic Gram-negative rods and certain Gram-positive bacteria. 
Streptomycin was found to be highly toxic (Toxnet, 2017), therefore the need of 
introducing new members of aminoglycosides such as Gentamicin, neomycin, 
tobramycin and amikacin. Gentamicin is less toxic and is widely used for infections 
caused by Gram-negative rods (Escherichia, Pseudomonas, Shigella and Salmonella. 
(Etebu et al., 2016) 
 
1.2.9 Sulphonamides 
Sulphonamides are reported as the first group of antibiotics used in therapeutic medicine, 
as they still play a very important role in medicine and veterinary practice. Sulphonamides 
inhibit both Gram-negative and Gram-positive bacteria such as Nocardia, E. coli, 
Klebsiella, Salmonella, Shigella, Enterobacter, Chlamydia trachomatis and some 
Protozoa and are widely used in the treatment of various infections including tonsillitis, 
septicemia, meningococcal meningitis and urinary tract infections. (Greenwood, 2010) 
 
1.2.10 Glycopeptides 
A Glycopeptide antibiotic is composed of glycosylated cyclic or polycyclic non-
ribosomal peptides. Vancomycin is among the most important glycopeptides, although 
teicoplanin is also available. Glycopeptide antibiotics act primarily by inhibiting the cell 
wall synthesis of bacteria. Vancomycin and teicoplanin have antimicrobial activity 
against almost all types of Gram-positive organism including MRSA. Vancomycin is also 
indicated for treating pseudomembranous colitis cause by Clostridium difficile, against 
which a limited number of antibiotic are effective. (Kuriyama, 2014)  
 
1.2.11 Oxazolidinones 
Oxazolidinones are a new group of antibiotics. These synthetic drugs are active against a 
large spectrum of Gram-positive bacteria, including methicillin- and vancomycin-
resistant staphylococci vancomycin-resistant enterococci, penicillin-resistant 
pneumococci and anaerobes. Rare development of oxazolidinone resistance cases were 
reported. (Bozdogan et al, 2004)  
Linezolid is used for treatment of respiratory tract and skin infections cause by Gram-











Antibiotic resistance occurs when bacteria evolve to evade the effect of antibiotics 
through multiple different mechanism. Certain bacteria are able to neutralize an antibiotic 
by altering its component to render it ineffective. Others might be able to export the 
antibiotics out of the bacteria, and some can modify their outer structure and receptors so 
that antibiotics cannot attach to them.  These mechanisms might lead to bacteria surviving 
the use of specific antibiotics and developing resistance that can be passed to other 
bacteria as they multiply. (Habboush et al, 2018) 
 
The crisis of antimicrobial resistance (AMR) is one of the most serious issues facing the 
world today. World Health Organization (WHO) published its first Global Report on 
Antimicrobial Resistance and concluded that, without intervention, we are heading for a 
post-antibiotic era, where minor infections and small injuries will once again be fatal. 
According to economist Lord O’Neil who published a report on the impact of AMR, if 
nothing is done, antibiotic resistance-related deaths would increase from 700,000 
annually to 10 million annually by 2050, overtaking cancer as the main cause of mortality. 
(Venter et al., 2017) 
 
1.3.2 Hospital-acquired infections 
 
The most widespread hospital-acquired infection, responsible for nearly 20,000 in-
hospital deaths every year in the USA alone, namely methicillin-resistant Staphylococcus 
aures (MRSA). In Europe, the percentage of S.aureus isolates reported as MRSA is not 
stabilizing and decreasing in most European countries. However, MRSA remains a public 
health priority as the percentage of MRSA is still above 25% in seven of 29 reporting 
countries, mainly in Southern and Eastern Europe. (ECDC, 2015) 
 
1.3.3 Methicillin-resistant S.aureus 
 
Same year that Alexander Fleming, Howard Florey and Ernst Chain received their Nobel 
Prize for the discovery and development of penicillin, the first strains of S.aureus resistant 
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to penicillin started to emerge. Resistance toward penicillin necessitated the development 
of methicillin, however just after 2 years of its introduction, resistance to methicillin was 
reported. MRSA strains are highly resistant against most β-lactams and many other 
classes of antibiotics. Vancomycin is the drug of choice for the treatment of infections 
caused by methicillin-resistant staphylococci. (Venter et al., 2017) 
 
1.3.4 Vancomycin intermediate S.aureus and Vancomycin-resistant S.aureus 
 
The National Committee for Clinical Laboratory Standards (NCCLS) defines 
staphylococci requiring concentrations of vancomycin of ≤4µg/mL for growth inhibitors 
as “susceptible”, those requiring concentrations of 8-16 µg/mL for inhibition as 
“intermediate” and those requiring concentrations of ≥32µg as “resistant”. (Weinstein et 
al., 2001). A strain of S.aureus with reduced vancomycin susceptibility (VISA) was first 
reported in 1997 in Japan. VRSA strains have also emerged but only a few cases were 
reported, and it does not represent an urgent public health threat. 
Currently, the advanced generation of cephalosporin ceftaroline, the lipopeptide 
daptomycin, vancomycin analogues telavancin and oxazolidinones linezolid and tedizolid 
can still be used against MRSA. (Venter et al., 2017) 
 
1.3.5 Resistance through the use of antibiotics in veterinary science and agriculture 
 
Colistin-resistance 
Colistin-resistant Acinetobacter spp. was first reported in the Czech Republic in 1999. 
(Cai et al., 2012).  
Colistin is characterized by remarkable antimicrobial activity against Gram-negative 
organism such as multidrug-resistant Pseudomonas aeruginosa, Acinetobacter 
baumannii, and Klebsiella pneumoniae as being considered the last line of defense caused 
by these organisms. It has been extensively used orally since the 1960s in food animals 
and particularly in swine for the control of Enterobacteriaceae infections caused by 
Escherichia coli. (Rhouma et al., 2016) 
Since its introduction on the market in the 60s, colistin was used in pig production in 
several countries with different purposes: therapeutically, prophylactically and even for 
growth promotion. (Katsunuma et al., 2007). 
The discovery of horizontal mechanism of colistin resistance raised alarm bells about the 
impact of colistin use on colistin resistance spread in animal production, especially in 
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swine. In fact, the link between pigs and humans in terms of colistin resistant E.coli strain 
transfer following direct contact has recently been confirmed. (Olaitan et al., 2015) 
Colistin is not used in agriculture in the United States but was the fifth most commonly 
used antimicrobial on farms in the European Union in 2011. (Catry et al., 2015) 
Since China used a vast amount of colistin in agriculture, it is likely selective pressure in 
the veterinary environment there led to E.coli acquiring mcr-1 gene. Recent news report 
that China has banned the use of this drug in animal feed in 2016, following the discovery 
of MCR-1. (CIDRAP, 2017) 
 
1.3.6 Resistance from farm to fork 
 
Several outbreaks of infectious disease caused by multidrug-resistant organisms, acquired 
through food sources, have brought the issue of the use of antibiotics in agriculture firmly 
into public attention. 
In 2014, a multistate outbreak of multidrug-resistant Salmonella heidelberg, in the USA 
was linked to consumption of chicken meat from one supplier. Prophylactic use of 
antimicrobials is huge, currently estimated at a global annual of 148 mg of antibiotic per 
kg of animal produced.  (Van Boeckel et al., 2015). 
A recent outbreak of multidrug-resistant Salmonella linked to raw chicken products was 
reported this year with 92 people infected with the outbreak strain of Salmonella Infantis. 
(CDC, 2018) 
 
Antibiotic-resistant bacteria may reach humans indirectly along the food chain through 
consumption of contaminated food or food derived products and following direct contact 
with colonized/infected animals or biological substances such as blood, urine, faeces, 
saliva and semen among others. Given the direct interaction of humans with the animal-
ecosystem interface, it is essential to prevent the zoonotic transmission of antibiotic-















1.4 Mechanisms of Antimicrobial Resistance 
 
Bacteria may manifest resistance to antibacterial drug through a variety of mechanisms 
discussed below.  
 
1.4.1 Intrinsic Resistance 
 
Intrinsic resistance is due to the physiological properties of a micro-organism, which are 
generally chromosomally encoded. (Walsh et al., 2008) Some microbes are naturally able 
to resist the antimicrobial activities of antibiotics due to their structure of functional 
processes. In one example, Enterococci species are intrinsically resistant to 
cephalosporins because this drug binds to a peptidoglycan binding protein (PBP) that 
these bacteria do not have. (Wolf, 2017) 
 
Another example, Klebsiella spp and Enterobacter spp are intrinsically resistant to 
ampicillin based on their production of beta-lactamases that destroy the drug before it can 
reach its PBP targets. (Wolf, 2017) 
Gram-negative bacteria generally have higher levels of resistance than Gram-positive 
bacteria. More specifically, Gram-Negative bacteria are innately resistant to penicillin G 
by virtue of their double membrane structure, which prevents the antibiotic from 
accessing the cell wall. Innate resistance is not considered a clinical problem because 
antibiotics were never intended for use against intrinsically resistant bacteria. (Walsh et 
al., 2008) 
 
1.4.2 Extrinsic Resistance 
 
Extrinsic resistance or acquired resistance occurs when a particular microorganism 
obtains the ability to resist the activity of an antimicrobial agent to which it was previously 
susceptible. This can result from the mutation of genes involved in normal physiological 
processes and cellular structures, from the acquisition of foreign resistance genes or form 
a combination of these two mechanisms. 
Unlike intrinsic resistance, traits associated with acquired resistance are found only in 
some strains or subpopulations of each particular bacterial species. Acquired resistance 
results from successful gene change and/or exchange that may involve mutation or 




1.5 One Health Approach 
 
One Health recognizes that the health of humans, animals and ecosystems are 
interconnected. It involves applying a coordinated, collaborative, multidisciplinary and 
cross-sectorial approach to address potential or existing risks that originate at the animal-
human-ecosystems interface. (CDC, 2018) 
 
To improve the effectiveness of the One Health approach, there is a need to establish a 
better sectorial balance among existing groups and networks, especially between 
veterinarians and physicians, and to increase the participation of environmental and 
wildlife health practitioners, as well as social scientists and development actors. 
 
In less than four years, One Health has gained significant momentum. The approach has 
been formally endorsed by the European Commission, the US Department of State, 
Centre of Disease and Control (CDC), WHO, NGOs, FAO, etc. 
 
The One Health concept is founded on an awareness of the major opportunities that exist 
to protect public health through policies aimed at preventing and controlling pathogens 
within animal populations, and the interface between humans, animal and the 
environment. 
The concept provides a better understanding of: 
• mechanism of human disorders 
• improve control and prevention of infectious agents 
• reduce economical losses due to diseases of livestock and crops 
• support the international efforts in campaign for sustainable environment. 
 
Antimicrobial resistance is a major challenge to global health. It has been estimated that 
if no action is taken against AMR, it will be the leading cause of death with 10 million 
victims per year by 2050. 
Therefore, countries all over the world have been developing approaches in line with One 
Health principles to tackle AMR. Following a report published in 2016, Review on 
Antimicrobial Resistance, by Jim O’Neil, there are 10 different perspective on how to 
tackle AMR (O'Neil, 2016): 
1. A global public awareness campaign 
2. Improve sanitation and prevent the spread of infections 
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3. Reduce unnecessary use of antimicrobial in agriculture into the environment 
4. Improve global surveillance of drug resistance and microbial consumption 
5. Promote new and rapid diagnostics 
6. Promote development and use of vaccines and alternative 
7. Improve the number and recognition of people working with infectious diseases 
8. A global innovation fund for early stage and non-commercial 
9. Better incentives to promote investment for new drugs and improving existing ones 
10. Build a global coalition for real action 
 
Compliance with Good Manufacturing Practices should be encouraged, as well as 
transparency in global supply chains and ethical procurement policies 
Antibiotic residues in ground and surface water should be monitored to ensure to be 
compliance with the European Commission’s strategic approach. 
International trade and increased mobility of people and animals are factors that require 
consideration, e.g. through imports of meat and other food products from countries that 
do not necessarily follow the same high standards as the EU, as drug resistant bacteria 
can easily cross continents. (EC, 2017). 
 
The EU scientific agencies (ECDC, EFSA, and EMA) have delivered on the Action Plan’s 
commitment to developing a set of key outcome indicators to assess progress on reduction 
of AMR and antimicrobial consumption. This provides an opportunity towards targets 
and goals supporting a reduction in AMR. 
The existing data/use, germ resistance levels, the number of healthcare associated 
infections or communicable diseases and the AMR burden should serve through the new 
Action Plan as a benchmark for national reduction target.  
In the veterinary field, a well-established system of surveillance and monitoring of sales 
of antibiotics in food producing animals has been implemented (EC, 2017) 
From a One Health Perspective, there are major data gaps regarding European 
surveillance and monitoring in all sectors of AMR: human medicine, agriculture and 
environment. 
 
European Antibiotic Awareness Day (EAAD) takes place every year on 18 November to 
raise awareness about the threat to public health from antibiotic resistance and the 
importance of prudent use of antibiotics. 
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The latest data confirms that across the European Union the number of patients infected 
by resistant bacteria is increasing and that resistance is a major threat to public health. 
(EFSA, 2018) 
Prudent use of antibiotics can help stop resistant bacteria from developing and keep 
antibiotics effective for future generations. 
 
1.6 Antibiotic resistance in the European Union 
 
   After a study conducted and published by ECDC - “Summary of the latest data on 
antibiotic resistance in the European Union” the conclusions show that antibiotic 
resistance is a serious threat to public health in Europe, leading to increased healthcare 
costs, prolonged hospital stays, treatment failures and also death. The data included in the 
study was collected by the European Antimicrobial Resistance Surveillance Network 
(EARS-Net), which is coordinated by ECDC. EARS-Net collects data on invasive 
bacterial isolates from 30 EU/EEA countries.  
 
  EARS-Net performs surveillance of antimicrobial susceptibility of seven bacterial 
pathogens commonly causing infections in humans: Escherichia Coli, Klebsiella 
pneumoniae, Pseudomonas aeruginosa, Acinetobacter pneumoniae, Staphylococcus 
aureus, Enterococcus faecalis and Enterococcus faecium. 
The latest summary from November 2016 shows that Resistance percentages were 
generally higher in southern and south-eastern Europe than in northern Europe. 
 
   For Klebsiella pneumoniae, combined resistance to three or more of the antimicrobial 
groups under surveillance was the most common resistance phenotype. Resistance to 
fluoroquinolones, third-generation cephalosporins and aminoglycosides, as well as 
combined resistance to all three groups, increased significantly at EU level, from 17.7% 
in 2012 to 18.6% in 2015, meaning that for patients who are infected with these multi-
drug resistant bacteria, only a few therapeutic options remain available. Among there are 
carbapenems, a last-line group of antibiotics. 
 
  However, carbapenem resistance percentages remained at low levels for most countries 
in 2015, resistance to carbapenems at EU level significantly increased in the past years, 
from a population weighted mean percentage of 6.2% in 2012 to 8.1% in 2015. A vast 
majority of the carbapenem-resistant isolates had additional resistance to 
fluoroquinolones, third-generation cephalosporins and aminoglycosides.  
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Ireland had a huge increase in combined resistance to fluoroquinolones, third generation 
cephalosporins and aminoglycosides, results taken from 312 isolates, in 2012 - 3.4%, in 
2013 -7.9% but then in 2014 slowly drops to 7.4% and in 2015 - 7.2%.  
 
   Antibiotic resistance in E. coli requires close attention as the percentages of isolates 
resistant to commonly used antibiotic continue to increase throughout Europe. 
Of particular concern is the increase in resistance to third-generation cephalosporins 
which increased significantly at EU level from 11.9% in 2012 to 13.1% in 2015 and 
combined resistance to third generation cephalosporins, fluoroquinolones and 
aminoglycosides which increased significantly at EU level from 4.9% in 2012 to 5.3% in 
2015. Again, the study of Ireland, on 2288 invasive isolates tested the levels raised from 
9.2% in 2012 to 11.4 in 2015 in regard to the resistance to third generation cephalosporins. 
 
  Acinetobacter species mainly cause healthcare-associated infections, such as pneumonia 
and bloodstream infections, and often result in hospital outbreaks if appropriate 
prevention and control measures are not implemented. 
Antibiotic resistance in Acinetobacter spp. showed large variations across Europe, with 
generally high resistance percentages reported from the Baltic countries and southern and 
south-eastern Europe. Combined resistance to fluoroquinolones, aminoglycosides and 
carbapenems was the most frequently reported resistance in 2015.  
 
  Methicillin-resistant Staphylococcus aureus (MRSA) as mentioned previous is one of 
the most frequent causes of antibiotic resistance healthcare-associated infections 
worldwide. The EU population weighted mean percentage decreased significantly from 
18.8% in 2012 to 16.8% in 2015. However, despite de positive outcome, MRSA remains 
a public health priority in Europe as 8 out of thirty countries reported MRSA percentage 
above 25%. Comprehensive MRSA strategies targeting all healthcare sectors remain 
essential for the reduction of the MRSA spread in Europe. 
 Enterococcus faecium and Enterococcus faecalis can cause a variety of infections, 
including endocarditis, bloodstream infections, and urinary tract infections. Vancomycin-
resistant enterococci (VRE) mainly cause healthcare-associated infections and often 
result in hospital outbreaks if appropriate prevention and control measures are not 
implemented. 
  Vancomycin resistance was more common in E. faecium than E faecalis and high 
percentages of vancomycin resistance was reported from countries in Eastern Europe. A 
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significant increase was observed in 12 out of 26 countries, reporting more than 20 
isolates per year.  (ECDC, 2016) 
 
1.7 Antibiotics use in Agriculture 
 
1.7.1 Treatment of farm animals 
The prevalence of pathogens on farms depends on many factors, such as type of 
husbandry, the environmental pressure on the farm, and the standard of the farm. The 
most commonly used antimicrobial drugs in animals reared for food are from the five 
major classes: β lactams, tetracyclines, aminoglycosides, macrolides and sulphonamides. 
The discovery of third generation fluoroquinolones with a broader spectrum of activity 
has led to interest in their use in animals. (Johnston, 1998) 
 
1.7.2. Prophylaxis 
Prophylaxis or strategic treatment is usually to contain the spread of infection and prevent 
illness before the development of clinical signs. It involves treating a herd or group of 
animals after illness has been diagnosed in one or more animals in the group. Diseases 
requiring the most extensive use of antimicrobial drugs for treatment or prophylaxis are 
respiratory and enteric diseases in pigs and cattle and mastitis in dairy cattle. (Johnston, 
1998) 
 
1.7.3 Performance enhancement  
The performance enhancement properties of antimicrobial drugs are used to improve the 
productivity of healthy animals by improving growth rate, feed conversion, or yield. The 
growth promoting properties of these agents in farm animals were discovered in the late 
1940s. In Europe, this activity has been banned since January 1, 2006. (EC, 2017) 
 
According to a survey on the most common antibiotics used to treat animals in Europe 
(2014), completed by 3000 veterinarians, shows differences in preferred antibiotics 
according to species and for the same indication in different countries. This may be due 
to differences in availability, different production systems or differences in veterinary 
prescribing behavior.  
Many older antibiotics (penicillins, tetracyclines, potentiated sulphonamides etc.) are still 
the ones that veterinarians most frequently say they would use to treat the main food 
producing species. The most important factors overall influencing a veterinarian to 
prescribe a certain antibiotic were sensitivity test results, their own experience, a 
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consideration of the risks of antibiotic resistance development and ease for 
administration. (Briyne et al., 2014). 
 
1.7.4. Cattle 
The predominant reason for antibiotic administration was for the control of mastitis in 
dairy cows, where antibiotic treatment may be given for clinical or subclinical mastitis. 
Third and fourth generation cephalosporins are cited to be the most frequent 
administrated, due to their very short withdrawal period. Data for calves were also 
available, reporting that diarrhea and respiratory diseases were the most frequent usage 
for antibiotic administration. 
 
1.7.5. Pigs 
The reported predominant use of antibiotics was for respiratory disease (mostly 
tetracyclines and penicillins) and diarrhea (mostly polymyxin and macrolides). A Belgian 
study reported that the most common antibiotic administrated to pigs was colistin, 
amoxicillin and doxycycline. (Callens et al., 2012) 
Some countries introduced a ban or restriction on the use of certain antibiotics in pigs. 
Denmark restricted the use of quinolones in 2002 and introduced a voluntary ban on use 
of third and fourth generation cephalosporins in 2010. 
 
1.7.6 Horses 
The predominant use of antibiotics was for skin diseases and respiratory conditions. The 
most frequently antibacterial administrated was penicillins followed by potentiated 
sulphonamides regarding if the horse is declared as companion animal or for food 
production. (Briyne et al., 2014) 
 
1.8 Use of veterinary antimicrobial agents  
 
In veterinary medicine, antimicrobials are used both for the treatment of individual 
animals and also for the medication of group animals, if required.  
 
In Ireland, medication of groups of animals is carried out most commonly in intensively 
reared farm animals such as pigs, poultry and farmed fish. 




EPRUMA (European Platform for Responsible Use of Medicines in Animals) defines 
therapeutic treatment as the treatment of animals following diagnosis of disease. 
Metaphylaxis is defined as medication of groups of animals when disease has been 
diagnosed in some members of the group, with the aim off treating the clinically affected 
animals, while preventing spread of disease to unaffected or sub-clinically affected 
animals. Prophylaxis is defined as medication of animals before clinical signs of disease 
in order to prevent the occurrence of disease. (FSAI, 2015) 
1.9 Regulatory Framework 
 
  Antimicrobial agents are animal remedies that are administrated by veterinarians and 
farmers to animals.  
The use of antimicrobial agents in food animals in governed by various pieces of 
European and Irish legislation relating to the production, distribution, supply and 
administration of medicine to food animals. 
At EU level, the primary legislation is set out in Directive 2011/82/EC, and at national 
level the primary legislation is the Animal Remedies Act No.23 of 1993. The detailed 
provisions are set out nationally (S.I No. 786 of 2007).  
 
  In addition to this medicine framework, other relevant legislative frameworks include 
those referring to residues, food safety, animal health and animal by-products including, 
Regulation (EC) No 882/ 2004 of the European Parliament and of the Council of 29 April 
2004 on official controls performed to ensure the verification of compliance with feed 
and food law, animal health and animal welfare rules is the legal framework for sampling 
methods and methods of analysis of feed for control purposes. 
 
The regulatory framework around animal remedies is designed around these concepts: 
• only medicines of adequate quality, safety and efficacy are administrated to animals 
• administration is restricted to circumstances where there is sufficient benefit to 
recipient animals 
• consumers of products derived from the recipient animals are protected from risks to 
their health related to the products (Walsh, 2010) 
The approach to ensuring the safety quality and efficacy is requiring the authorization of 
all animal remedies by a competent authority, following demonstration of the appropriate 





In Ireland this responsibility rests with the Health Products Regulatory Authority 
(HPRA). Only products which have been allocated a Veterinary Product Authorization 
(VPA) may be sold or administrated to animals. (FSAI, 2015) 
 
However, there is an exception, known as the “cascade” in which there is no authorized 
product to treat a particular illness therefore a veterinary practitioner may use human 
medicine authorized by HPRA or an animal remedy authorized in another Member state 
of the EU. In the case of food animals, only substance with a Maximum Residue Limit 
(MRL) may be used and minimum withdrawal periods apply. 
The VPA of each animal remedy categorizes remedies to designate the allowable supply 
route for that formulation: 
• VSO. Veterinary Surgeon-Only. These may only be dispensed and administrated by a 
veterinary practitioner. 
• POM. Prescription Only Medicine. These remedies may only be dispensed according 
to a prescription by a veterinary surgeon. Their dispensing and administration may be 
done by non-veterinarians in accordance with the veterinary prescription. 
• Pharmacy only (PS) or Licensed Merchant (LM) products may only be dispensed by a 
pharmacy or by a licensed merchant. (Walsh, 2010) 
 
A key part of the regulatory basis for administering animal remedies to food animals is 
the management of risks that might arise to consumers through the consumption of the 
food products harvested from those animals, e.g. meat, milk, eggs or honey. The decline 
of concentration of the remedy within animal tissues after administration is assessed and 
a withdrawal period (the minimum duration from administration until harvesting of food 
from an animal) is established for all remedies authorized for use in food animals. 
 
Distributors, suppliers, prescribers and administrators of animal remedies are required to 
maintain appropriate records, and the on-farm remedy register should support compliance 
by farmers in deciding when to allow food products enter the food chain. (FSAI, 2015) 
 
The European Medicines Agency is a decentralized body of the EU. Its main 
responsibility is the protection and promotion of public and animal health, through the 
evaluation and supervision of medicines for human and veterinary use. The Agency is 
responsible for the scientific evaluation of applications for European marketing 




The European Surveillance of Veterinary Antimicrobial Consumption (ESVAC), 
following a request from European Commission to collect and report data on the use of 
antimicrobial agents in animals from the Member States. 
In the following charts, data from 30 European countries was collected in relation to the 
use of antimicrobials in 2016.   
A population correction unit (PCU) is applied as a proxy for the size of the food-
producing animal population (including horses). The main indicator used in the current 
report to express the sales is milligrams of active ingredient sold per population correction 
unit — mg/PCU. 
 
1) The sales of veterinary antimicrobial agents, expressed as mg sold per population 
correction unit (PCU), ranged from 2.9 mg/PCU to 453.4 mg/PCU across the 30 
EU countries, mainly for food producing animals, in 2016. (ESVAC, 2018) 
 
Country Sales (tonnes) for food producing 
animals 
PCU mg/PCU 
Austria 44.1 957 46.1 
Belgium 240.4 1.715 140.1 
Bulgaria 61.1 393 155.3 
Croatia 26.6 286 92.9 
Cyprus 46.3 102 453.4 
Czech Republic 43.2 705 61.2 
Denmark 98.7 2.420 40.8 
Estonia 7.2 113 64.0 
Finland 9.7 521 18.6 
France 513.9 7.143 71.9 
Germany 779.2 8.734 89.2 
Greece 79.9 1.258 63.5 
Hungary 155.6 832 187.1 
Iceland 0.6 120 4.7 
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Country Sales (tonnes) for food producing 
animals 
PCU mg/PCU 
Ireland 102.3 1.963 52.1 
Italy 1,213.2 4.116 294.8 
Latvia 5.4 180 29.9 
Lithuania 12.7 338 27.7 
Luxemburg 1.9 55 35.5 
Netherlands 181.7 3.446 52.7 
Norway 5.6 1.896 2.9 
Poland  570.2 4.407 129.4 
Portugal 210.9 1.014 208.0 
Romania 265.4 3.116 85.2 
Slovakia 12.2 242 50.4 
Slovenia 5.4 178 30.3 
Spain 2,724.9 7.518 362.5 
Sweden 9.8 805 12.1 
Switzerland 37.6 806 46.6 
UK 321.7 7.142 45 
Table 2. Sales of veterinary antimicrobial agents in 30 European countries in 2016, Eight 
ESVAC report (ESVAC, 2018) 
 
Variations in sales may be due to the differences between the countries in the proportion 
of the various food producing animal species, the availability of veterinary antimicrobial 
products on the market, prices, animal-production systems, the general situation regards 
to animal disease, vaccination programmes, management and implementation of 















2) Sales of antimicrobial agents by antimicrobial class as percentage of the total sales for 




Figure 3. Sales of antimicrobial agents by antimicrobial class, by 30 European 
countries, in 2016 (ESVAC, 2018) 
 
 
Of the overall sales of antimicrobials in the 30 countries in 2016, the largest amounts, 
expressed as a proportion of mg/PCU, were accounted for by tetracyclines (32%), 
penicillins (26%) and sulfonamides (12%). Overall, these three classes accounted for 70% 





































3) Distribution of sales, in mg/PCU, of the various pharmaceutical form of veterinary 




Figure 4. Distribution of sales of the various pharmaceutical form of veterinary 
antimicrobial agents in food producing animals, 2016 (ESVAC, 2018) 
 
 
Across the 30 countries, the sales (mg/PCU) of pharmaceutical forms for group treatment 
accounted for 90.1% of the total sales: premixes accounted for 40.8%; oral powders for 
11.9%; and oral solutions for 37.4%.The proportion accounted for by pharmaceutical 
forms for group treatment varied substantially between countries, ranging from 5% to 
96%. Of pharmaceutical forms for treatment of individual animals (9.9%), 9.0% of the 
sales were accounted for by injectable preparations, 0.6% by intramammary preparations 


























4) Estimated PCU (in 1,000 tonnes) of the population of food producing species, by 
country, in 2016 
Country Cattle Pig Poultry Sheep/g
oats 
Fish Rabbits Horses Total 
Austria 441 369 80 35 0 0 32 957 
Belgium 455 882 236 16 0 4 121 1.715 
Bulgaria 130 83 47 100 0 0.1 33 393 
Croatia 111 90 38 47 0.02 0.004 0.1 286 
Cyprus 17 45 13 25 0 0.1 2 102 
Czech 
Republic 
294 205 127 18 21 8 32 705 
Denmark 398 1.773 123 13 43 0 70 2.420 
Estonia 60 38 2 7 1 0.003 4 113 
Finland 224 166 73 13 14 0 30 521 
France 3,240 1,815 1,145 642 45 47 211 7.143 
Germany 3,161 3,807 1,071 137 19 20 520 8.734 
Greece 96 116 128 784 123 0 11 1.258 
Hungary 149 346 193 97 23 2 21 832 
Iceland 19 6 6 47 15 0 27 120 
Ireland 1,184 276 91 308 44 0 60 1.963 
Italy 1.592 847 755 590 171 29 132 4,116 
31 
 
Country Cattle Pig Poultry Sheep/g
oats 
Fish Rabbits Horses Total 
Latvia 111 37 19 8 0 0.1 4 180 
Lithuania 192 72 56 12 0 0.1 7 338 
Luxembour
g 
40 12 0.1 1 0 0 2 55 
Netherlands 1,174 1.685 398 94 62 1 33 3.446 
Norway 214 130 68 108 1.326 0 50 1.896 
Poland 1,547 1.453 1.266 18 0 2 121 4.407 
Portugal 228 359 220 174 10 6 18 1.014 
Romania 929 553 453 1.001 7 0.002 173 3.116 
Slovakia 93 55 56 31 2 0 4 242 
Slovenia 98 19 40 9 2 0.02 11 178 
Spain 918 3,738 834 1.437 308 68 216 7.518 
Sweden 298 198 105 48 13 0 142 805 
Switzerland 477 203 70 34 0 1 22 806 
UK 1.792 789 1.151 2.845 187 0 378 7.142 
Table 3. Estimated PCU (in 1000 tonnes) of the population of food producing species, by 
country, in 2016 (ESVAC, 2018) 
 
Overall, pigs, cattle, poultry and sheep/goats accounted for 32%, 31%, 14% and 14%, of 
the PCU in the 30 countries. 
 
In total, 25 countries provided data for all years between 2011 and 2016. For these 
countries an overall decline in sales (mg/PCU) of 20.1% was observed. Sales fell from 
162.0 mg/PCU in 2011 to 129.4 mg/PCU in 2016. A fall in sales (in mg/PCU) of more 
than 5% was observed in 16 of these countries (in the range -8.7% to -57.8%), whilst 
there was an increase of more than 5% in six countries during the reference period (a 




The European Centre for Disease Prevention and Control (ECDC)/European Food Safety 
Authority (EFSA)/EMA second joint report on the integrated analysis of the consumption 
of antimicrobial agents and occurrence of AMR in bacteria from humans and food-
producing animals (JIACRA II report), while recognizing the complexity of evaluating 
the association between the sales of antimicrobials and occurrence of AMR in animals 
and humans, confirms that reduction of the sales of antimicrobials is a desirable objective 
in order to contain AMR.  
 
EFSA, ECDC and EMA have jointly established a list of harmonized outcome indicators 
to assist EU Member States in assessing their progress in reducing the use of 
antimicrobials and occurrence of AMR in both humans and food producing animals. 
 
1.10 Antimicrobial resistance and the food chain 
 
 
Investigating the zoonotic antimicrobial resistance problem in its full complexity requires 
monitoring of antimicrobial usage and resistance in all relevant reservoirs and stages in 
the transmission route. 
Already in the early 1960, findings of resistant Salmonella in food animals and humans, 
and studies that showed that they could pass their resistance traits on to other enteric 
bacteria. In the mid-1990s the detection of vancomycin-resistant Enterococcus faecium 
as well as quinolone-resistant Salmonella and Campylobacter in food animals and 
evidence of their spread to humans elevated the scientific and public concerns to new 
levels. (Wegener, 2012) 
 
Recently a number of antimicrobial-resistant pathogens have emerged in the food-
production chain: extended beta-lactamase producing Salmonella and Escherichia coli, 
transmissible quinolone resistance in Salmonella and E.coli and animal-associated 
methicillin-resistant Staphylococcus aures (MRSA), which can transmit to, and cause 
infections in humans. These emergences can all associated with the use of antimicrobial 












Foods of animal origin are considered to be an important source of antimicrobial-resistant 
bacteria entering the food chain (EFSA 2008). The main focus of concern the acquired 
resistance by the animal on the farm. Foods of animal origin may also act as a potential 
vehicle for human-to-human transmission of antimicrobial-resistant bacteria. 
Foods of non-animal origin are recognized as an important source of foodborne infection 
in Europe. Based on reported European outbreak data from 2007 to 2011, foods of non-
animal origin were associated with 10% of the outbreaks (EFSA 2013). EFSA identified 
Salmonella spp in leafy greens, tomatoes, melons; Escherichia Coli in fresh pods, 
legumes or grains. Foods of non-animal origin may become contaminated during primary 
production or at a later stage. 
 
1.11.1 Import of food of animal origin 
 
  Food of animal origin from third countries can only be imported into EU from approved 
processing plants (EC, 2006). The third countries production systems need to be 
compliant with the equivalent standard and is verified through audits by the Food and 
Veterinary Office of the EU Commission Directorate-General for Consumer Health and 
Protection (DG-SANTE, 2010). 
  Imported food is being verified by the official control at the borders and sent for 
laboratory analysis carried in the EU Border Inspection Posts. 
 
1.11.2 Import of non-animal origin 
 
  Depending on the risk level, food of non-animal origin is going through three levels of 
control. There is free movement within the EU of food of non-animal origin produced in 
EU. Routine official controls are carried out on all products of non-animal origin entering 
the EU from the third countries unless a high risk is identified, and controls are increased. 
Increased controls are carried under the Regulation (EC) No 669/2009. Certain foods are 
verified to check the compliance with specific EU legislation, e.g. mycotoxins, pesticide 
residues and microbiological safety. (DG-SANTE, 2010) 
 
  As there is no EU standard for Antimicrobial-resistant bacteria in food, consideration 
for sampling for AMR are not part of the border control process. Once a product entered 




1.11.3 Water and Primary Production 
 
Drinking water can act as a direct vehicle for transmission of antimicrobial-resistant 
bacteria when contaminated with animal or human faeces and can also be a potential 
vehicle for antimicrobial residues. 
Waterborne contamination of food may arise during primary production, e.g. 
contaminated irrigation water on crops, or food processing e.g. a contaminated ingredient. 
(FSAI, 2015). Disposal of manure and slurry on farms is also a concern which is being 
regulated by the Statutory Instrument No.610 of 2010 for the protection of waters. 
 
Both human and animal by-products are a potential source of environmental 
contamination with antimicrobial-resistant bacteria which may impact on animal feed and 
food. These materials are of particular concern when spread on land where ready-to-eat 
crops are grown. Animal manures and municipal sludge have been shown to contain 
antimicrobial-resistant bacteria. When antibiotics are administered to an animal, some 
parts of the antimicrobial may be shed in urine, faeces and other body fluids. This may 
lead to a selection of resistant bacteria. 
 
In a recent UK study, 83% of farmers fed milk from cows with mastitis to calves and only 
one third of these discarded the milk from the first milking after antimicrobial treatment 
(Brunton et al., 2012). High number of Swedish farmers also fed milk likely to contain 
antimicrobial residues to calves. The percentage of resistant faecal E. coli in calves fed 
such milk was higher than in calves fed milk without antimicrobial residues. (EFSA, 
2016). Milk from animals which has been treated with antibiotics and which is 
temporarily redraw from the human food chain as a result of this treatment, is an animal 
by-product. If this milk is not used or disposed of the farm of origin, this is subject to 
ABP legislation Reg. EC. No.1069/2009.  
 
Food handlers are also a potential source of antimicrobial-resistant organisms and may 
contaminate food. Therefore, food producing companies must implement and control 
Good Hygiene Practice, Good Manufacturing Practice and a HACCP plan to ensure the 
safety of the site. Inadequate cleaning of housing between flocks and herds may help 









Salmonella enterica is a major cause of bacterial enteric illness in humans and animals 
and is notably the second leading cause of zoonotic infection in the European Union. 
(Gupta et al., 2004) 
In 2006, 1.3% of the raw poultry meat tested at the processing level was positive for 
S.enterica, followed by 5.3% in 2007.  
S. Typhimurium was the most frequently isolated serotype from pork and pork meat 
products in 2006 and 2007. A very low proportion of beef, veal and associated products 
were found to be contaminated with S. enterica at the processing level, compared to none 
at the retail level in 2006 and 2007. (SafeFood, 2010) 
 
 
Antimicrobial resistance in Salmonella spp. 
 
In Ireland, studies show an increase in antibiotic resistance in Salmonella spp. isolates 
from diseased animals, environment and feed-stuffs. A recent study of Salmonella spp. 
isolated from post evisceration pig carcasses and caecal contents, indicated a high 
incidence of S. Typhimurium in caecal contents (19%) and on carcasses (24%). 
(McDowell, 2007) The increased level of resistance to nalidixic acid is of clinical 
importance. 
Porcine isolates tend to be resistant to a greater number of antibiotics than bovine or 
ovine, and turkey isolates are resistant to a greater number of antibiotics than chicken 
isolates. No resistance to third generation cephalosporins or ciprofloxacin have been 
detected in any animal isolates.  
 
Intra-species differences may reflect on the intensity of the farming methods, for example, 
pigs are intensively reared indoors, where illness in one animal is easily spread through 
the herd, and the herd is being treated, whereas cattle or sheep are field farmed and are 
treated as individual animals. 
 
The age of the infected animal is also important. Salmonella spp. from calves are 
significantly more resistant to antibiotics than from older bovine animals (EFSA, 2006), 
and the reason is unclear. 
There is currently an outbreak of antibiotic-resistant Salmonella in the US from turkey 
that has infected 164 people across 35 states. The supplier has not been identified and the 
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outbreak has reached every turkey product from cold cuts to raw, whole turkey to pet 
food, according to mass media. 
 
Another recent outbreak occurred in October 2018, where antibiotic-resistant Salmonella 
has sickened 92 people and has been traced to raw chicken from multiple sources and 
sold under various brands. Whole-genome sequencing of Salmonella isolates found in 43 
of the patients and 68 food samples predicted the bacterial infection was resistant to 
multiple antibiotics. (CDC, 2018) 
 
1.12.2 VTEC - Pathogenic E. coli 
 
E. coli is arguably the best known and most intensively investigated group of the bacteria 
found in humans and warm-blooded animals. (Sungsu Park, 2001) 
Verocytotoxigenic Escherichia coli (VTEC), in particular serotype O157, are an 
important cause of gastrointestinal illness. They have emerged as significant pathogens 
causing a range of severe and fatal illnesses. Infection can be transmitted through food, 
contaminated water, the environment and by direct contact with animals or human. 
The presence of VTEC in food is of particular concern, as the minimum infection dose is 
estimated to be as low as 10 viable cells. (Walsh, 2010) 
 
Antimicrobial resistance in VTEC 
 
To date, antibiotic resistance in VTEC has received little research attention. This is mainly 
because antibiotic therapy is not recommended in case of VTEC-associated infection and 
VTEC-strains have been reported to be slower to acquire resistance than generic E. coli 
strains. However, multi-resistant strains of VTEC have been isolated from foods, 
suggesting increasing proliferation of antibiotic resistance among VTEC. (SafeFood, 
2010) 
Some information is available based on the veterinary and human clinical cases which 
suggests that the incidence of antimicrobial resistant E. coli O157:H7 remains very low 
in cattle and sheep isolates, low in pig isolates, and with the exception of tetracycline, 
very low in human clinical isolates. 
 
A study conducted in Romania in order to assess the antimicrobial resistance patterns of 
E. coli isolated from young animals between years 1980-2016 found that resistance to 
tetracycline and streptomycin was the most frequent co-resistance phenotype (37%). 
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Multi-drug resistance increased from 11% during 1980 to 40% between years 2000-2016. 




Campylobacter is the most commonly reported cause of bacterial foodborne infection in 
the EU followed by Salmonella. It can be transmitted to humans either directly or 
indirectly. Direct transmission can occur via contact with animals, carcasses or water 
which has been infected. Indirect transmission can occur through the ingestion of 
contaminated food or water. In the US, the highest risk factor for campylobacteriosis is 
the consumption of commercially-prepared chicken. (Rocourt, 2003) 
 
Studies made in Ireland show that Campylobacter was isolated most frequently from retail 
poultry (chicken 49.9%, turkey 37.5% and duck 45.8%). However, data from EU showed 
that the incidence of Campylobacter spp in fresh poultry meat at slaughter ranged 
considerably from 4.6% to 56.1%. 
Research has shown that by the third or fourth week of production, most poultry flocks 
are contaminated to some extent with Campylobacter spp, resulting in the eventual spread 
of the organism to almost all members of the flock. (Walsh, 2010) 
 
Since consumption of poultry is one of the major risk factors in acquiring 
campylobacteriosis it is worth considering the impact of poultry processing on antibiotic 
resistance of this pathogen. 
Slaughter and processing provide opportunities for reducing C. jejuni counts on food-
animal carcasses. Bacterial counts on carcasses can increase during slaughter and 
processing steps. In one study, up to a 1000-fold increase in bacterial counts on carcasses 
was reported during transportation to slaughter.  
 
Research studies carried out on chickens and turkeys at slaughter, found that bacterial 
counts increased by approximately 10 to 100-fold during defeathering with the highest 
level found after evisceration.                                                                                                                                                                                                                                                                    
During the slaughter of cattle and swine, fresh carcasses are cooled by forced air 
ventilation. This treatment both temporally freezes and dries the surface, and this process 
has been documented to effectively reduce the number of Campylobacter cells on the 
surface of carcasses. Therefore, meat which is dried, cured, salted, smoked, irradiated or 
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exposed to any other preservation methods, will also harbor less Campylobacter 
compared to the unpreserved product.                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                           
 
Antimicrobial resistance is a common feature of Campylobacter isolated from food of 
animal and non-animal origin. In a European study in 2006, Campylobacter isolates from 
poultry meat were found to have a high level of resistance to ciprofloxacin (30.6%) 
(Piddock, 2006). Resistance to this antibiotic was also high in isolates from fowl, pigs, 
and cattle. 
 
Resistance to tetracycline was found to be very common (EFSA, 2006). In food animals, 
the prevalence of resistance to erythromycin is generally higher in C.coli, in particular in 
C. coli isolates from pigs than in C. jejuni. (Enberg et al., 2001) 
 
In Spain, it was found that the rates of erythromycin and quinolone resistance in C.coli 
from pigs were 81% and 100% (Saenz et al., 2000) 
Antibiotics used in high concentrations in animal feed can be found in animal manure, 
which can end up as plant fertilizer. 
 
It has been reported that a high proportion of animal Campylobacter spp are resistant to 
ampicillin/tetracycline (>40%) and ciprofloxacin/nalidixic acid (>20%). A report of 
Randall et al., suggested that 3.8% of Campylobacter spp. from combined human and 
animal origins were multi-resistant. 
 
In general, Campylobacter spp isolated from pork and poultry have higher and broader 
resistance to antibiotics than lamb or beef. This may be due to the intensive farming 
methods used in pig and poultry rearing, where mass medication is relatively common 
and high stocking levels may facilitate dissemination of pathogens and AMR genes 
between animals. (Turnidge, 2004) 
 
Most cases of human Campylobacter enteritis do not require antimicrobial treatment, as 
the symptoms are usually clinically mild. A survey conducted in Ireland, found that only 
7.4% of those with acute gastroenteritis reported were taking antibiotics (Walsh, 2010). 
However, this can get to a more severe illness including diarrhoea, abdominal cramps and 
vomiting which can last for days. The use of quinolones (ciprofloxacin) is considered to 
be the first choice as they are also considered useful for the prophylaxis of travellers 
diarrhea. (Piddock, 2006) 
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There are examples from many countries where fluoroquinolones-resistance rates are 
similar in isolates from poultry products and humans (Saenz et al., 2000) 
 
1.13 Antimicrobial Resistance and the Consumer 
 
1.14.1 Antibiotics and general public 
One of the most important steps in fighting antimicrobial resistance is revising the 
knowledge of the general public. 
Educational campaigns for the public play a vital role in this area. Creating a good 
campaign requires actual knowledge of the target population and continual assessment of 
the campaign’s effectiveness. European studies as well as international studies on the 
social knowledge of antibiotic use and antimicrobial resistance indicate a widespread 
ignorance regarding the ineffectiveness of antibiotic treatment for viral infections along 
with the knowledge of the difference between bacteria and viruses. 
Studies from Kuwait and Sweden confirm a confusion among the public regarding 
whether antibiotics are effective against bacteria or viruses. 
A study conducted in USA shows that a high percentage of respondents not only did not 
understand the difference between viral and bacterial infections, but also did not 
understand the indications for antibiotic treatment.  
The world literature indicated that the percentages of bacterial resistance to antibiotics is 
correlated with the intensity of usage of these drugs. Therefore, self-medication plays an 
important role in driving resistance. Two types of behaviours are known to contribute to 
this phenomenon: obtaining antibiotics from pharmacy without a prescription or 
obtaining them from a non-medical source (e.g. leftover from previous course). 
According to the Eurobarometer 478 Report, published in November 2018 on 
Antimicrobial Resistance the main findings across the European Union countries were: 
 32% of Europeans took antibiotics in the last 12 months 
 20% of Europeans took antibiotics for flu and cold 
 7% of them took antibiotics without a prescription or seeing a medical 
practitioner. 
 41% of them took antibiotics after a diagnosis test 
 85% are aware that unnecessary use of antibiotics makes them become 
ineffective 
 56% agree that sick animals should be treated with antibiotics if appropriate 




The report concludes that there has been a small drop since 2016 in the proportion of 
Europeans taking antibiotics in the previous 12 months and it is now at its lowest level 
since 2009. (40% in 2009 and 32% in 2018). (EC, 2018) 
Overall, there remains significant scope to improve Europeans Knowledge about 
antibiotics reflecting the surveys findings. The challenge remains to reduce the overuse 
of antibiotics and reduce incorrect usage. 
 
1.14.2 Consequences of foodborne antimicrobial resistance for the consumer 
 
Antimicrobial resistant pathogenic bacteria may be ingested by consumers and present a 
immediate risk for public health. The consequences of antimicrobial resistant Salmonella 
and Campylobacter have been studies repeatedly. The studies revealed that the emerging 
resistance of these foodborne pathogens result in an increase in the number of 
hospitalizations and increase the risk of invasive infections and mortality. 
Antimicrobial resistant genes present in foodstuff, either contained in bacteria and 
bacteriophages or as DNA fragments, may involve an indirect risk for public health as 
they increase the gene pool from which pathogenic bacteria can pick up antimicrobial 
resistance genes and possibly transfer them to other bacterias. (Verraes et al, 2013) 
 
In vitro studies demonstrated the transfer of erythromycin resistance genes from LAB to 
Listeria spp.  
Antimicrobial resistance in commensals constitutes and indirect public health risk as 
antimicrobial resistance may be transferred to pathogens. E. coli strains which are 
ingested with food may contain extended spectrum Beta-lactamase genes that are located 
on mobile genetic elements. Therefore, it is possible that cephalosporin resistance is 
transferred to pathogens in the human digestive system. 
Colistin-E. coli with plasmid mediate resistance has been recently reported in Denmark 
in imported frozen poultry and transmission through the food chain to humans has been 
demonstrated. Plasmid mediated resistance to colistin has also been identified in 










CHAPTER 2: METHODOLOGY 
 
2.1 Aims and Objectives 
 
The aims of this survey were: 
 
• An overview of public perception and antibiotic resistance 
• Examination of antibiotic use by the consumer 
• To examine the frequency of antibiotic intake 
• To determine consumer’s source of antibiotics 
• To determine current awareness of antibiotic resistance 
• To determine consumers perception towards the association between antibiotic use in 






In order to meet the listed objectives, research was conducted through the distribution and 
completion of questionnaires by members of the public.  
 
2.2.2 Questionnaire Design 
 
A questionnaire was developed to determine consumer perception of antibiotics use and 
the antibiotic resistance problem. The questionnaire consisted of 22 questions. The 
questionnaire was created directly on Google Forms. 
 
2.2.3 Question Structure 
   Self-completion questionnaires were chosen as they are the most common way of 
collecting data. They can be opened or closed questions. The author chose the closed 
question technique. The respondent is asked a question and required to answer. They 
provide a range of answers and so reduce the chance that the respondent will give an 
ambiguous answer (Moore, 2000)  
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 A 22-question survey (as per Appendix 1) was designed to analyze consumer’s 
perception and knowledge on antibiotic use and antibiotic resistance. The survey had an 
approximate 7-minute completion time. 
 
The Google Form survey was available from the 11th of October until 26th of November 
and 763 completed forms were collected. The completed forms were analyzed and 
transformed into graphical presentations (pie charts and bar charts). Findings were also 
recorded in an Excel database and statistically analyzed in SPSS. 
 
2.2.4 Research population 
There was no restriction in target participants. The questionnaire was targeted for general 
public, based in Ireland. 
 
2.2.5 Pilot Study  
A pilot study was carried out to determine whether the terminology, wording and content 
of the questionnaire was satisfactory. It was important that only relevant questions were 
asked and that they linked directly with the objectives required. The pilot study was 
carried out on 5 consumers.  
 
The pilot study identified issues related to question and answer structure. For example, 
question 20, 3 out of 5 respondents notified a ranking scale of 1 to 3 instead of 1 to 5 as 
initially set. The author identified the scale error on mobile devices only. In order to avoid 
any confusions and facilitate the completion of the questionnaire both on mobile and 
online the author change the question ranking scale from 1 to 5 to 1 to 3.  Following post 
trial, the author amended the issues identified. 
 
2.2.6 Questionnaire Circulation 
It was decided on the approach of an online questionnaire to be circulated on multiple 
online platforms such as emails, Facebook and WhatsApp. The highest number of 
responses came from social media. The author posted the survey link on various groups 
on Facebook. The response rate was surprisingly high with 600 responses recorded in 36 
hours following link distribution on social media.  
The survey was distributed on social media and included residents from Ireland.. 




2.2.7 Data analysis 
The results from the survey could be viewed as soon as the questionnaire was completed 
by the participant and submitted online. The number of responses received at any time 
could be checked by simply logging onto the site and viewing the status of the survey. 
Upon reaching the deadline for the completion of the survey, all 763 were analyzed using 
advanced software functions of Google Forms and Excel. The data was further analyzed 

































CHAPTER 3: RESULTS 
 
Survey Question 1. What is your gender? 
 
 
Gender Research Sample (n=763)  
 Frequency  Percentage 
Male  155 20.2 
Female 608 79.8 
Table 4.  Gender distribution of respondents 
 
          
Figure 5. Demographic profile of respondents: Gender (n= 763) 
 
As given in the table 1, out of 763 people that completed the questionnaire, 79.8% of 
these were female and 20.2% were male. Research show that females are more inclined 


















Survey Question 2: What is your age? 
 
 
Table 5. Age distribution of respondents (n=763) 
 
        
Figure 6. Demographic profile of respondents: Age group (n=763) 
 
Figure 2 presents the profile of the respondents in terms of their age. Out of 764 
respondents, 49% are in the age range of 30-49 years old, 45% are young adults 18-29 









over 65 years old
Age group   Research Sample (n=763)  
 Frequency Percentage 
18 to 29 years 284 45% 
30 to 49 years 290 49% 
50 to 64 years 35 5% 









Survey Question 3: What is the highest level of education you have completed? 
 
 
     
 Others consisted of: “foundation degree”; “high-school”; “nursing”  
Figure 7. Level of education (n=763) 
 
Figure 3 shows that the vast majority of the respondents (34%) had a certificate/diploma, 
followed by Bachelor’s Degree with 32.8%, 24.9% had a Postgraduate Degree, and a 




































Figure 8. Consumer’s response to the first symptoms of an illness (n=763) 
 
As shown in the figure above the vast majority of the respondents (57.3%) are trying to 
avoid taking antibiotics to treat the first symptoms of an illness, unless is absolutely 
necessary. The other 25.5% of respondents are trying to manage without the antibiotic 
but would consider it in cases e.g. ‘if  an infection worsens’ and 13.8% are even using 
alternative treatments such as holistic medicine to treat the illness.  These results indicate 
a reticence among the majority of consumer to take antibiotics, unless necessary, 
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Survey Question 5: How often would you typically take antibiotics in a year? 
 
 
            
Figure 9. The frequency of antibiotic intake (n=763) 
 
Figure 5 finds that 49.2% of the respondents take antibiotics usually once or twice a year. 
A group of 41.5% responded that practically they never take antibiotics. For 55 
respondents (7.2%) their antibiotic intake is from three to four times a year, and there is 
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The relationship between age group and frequency of antibiotic intake 





Vertical axis; Age (0=18-29 years old; 1=30-49 years old; 2= 50-64 years old; 3=over 65 
years old) 
Horizontal axis; Frequency of antibiotic intake (0=usually once or twice a year; 1=usually 
3 or 4 times a year; 2=usually more than that (>3-4); 3=practically never) 
 
Table 6c 
Pearson Chi-Square test was conducted independently to ascertain the relationship 
between age groups and antibiotic intake.  which was found to be statistically significant 











Figure 10. The intake of antibiotics in the last 12 months (n=763) 
 
The figure above represents the respondent’s intake of antibiotic in the last 12 months. 
The answer was quite balanced, the highest percentage 49.5% responded positive and a 



























Survey Question 7. How did you obtain the last course of antibiotics used? 
 
 
       
    * Others consisted of: “over the counter”, “friends”, “pharmacists” 
                     Figure 11. Source of antibiotic course (n=763) 
 
 
Figure 11 shows that the majority of the respondents obtained their last course of 
antibiotics with a medical prescription from a qualified health care practitioner. 48 
respondents had leftovers from the previous course which they used and 2.5% had 
selected other, such as buying the medication abroad over the counter. Some respondents 































 Others consisted of:  ‘’after a few days’’ 
Figure 12. Discontinuation of antibiotic course (n=763) 
 
Four out of five respondents (79.7%) correctly say that antibiotic treatment should only 
be stopped when all the antibiotics have been taken as directed. Nevertheless, around 1 
in 8 respondents (19%) incorrectly think that they should stop taking antibiotics when 
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Survey Question 9: Would you consider taking a probiotic after an antibiotic course? 
 
 
              
Figure 13. Probiotic intake after an antibiotic course (n=763) 
 
The majority of the survey respondents would consider taking a probiotic after an 
antibiotic course. Almost a third of respondents would not consider taking probiotics and 
15.7% are not sure, even though it is scientifically analysis shows that probiotics help 


























Survey Question 10: Would you consider taking an antibiotic for a cold or flu? 
 
 
           
Figure 14. The use of antibiotic for a cold or flu (n=763) 
 
 
Figure 14 shows that the majority of respondents would not take antibiotics for a cold or 
flu, 14% said that maybe they would and 7.6% of the respondents would take antibiotics 


























Survey Question 11: In your opinion, are antibiotics effective against viral infections? 
 
 
        
Figure 15. Antibiotics against viral infections (n=763) 
 
 
This figure shows the consumers personal opinion on the effectiveness of antibiotics 
against viral infections. Almost half of the respondents answered that the antibiotics are 
not effective against viral infections, 18.4% answered positive and the a third of them 
























The relationship between the level of education and consumers opinion if antibiotics are 
effective against viral infections 






Vertical axis; Level of education (0=Secondary level; 1=Certificate/Diploma; 
2=Bachelor’s Degree; 3=Postgraduate Degree; 4=Others) 
Horizontal axis; Are antibiotics effective against viral infections? (0=yes; 1=no; 
2=sometimes; 3=I don’t know) 
 
Table 9c 
Pearson Chi-Square test was conducted independently, and got a value of p=0.003, which 












Figure 16. Unnecessary use of antibiotics makes them become ineffective (n=763) 
 
 
More than 1 in 5 respondents (81.6%) correctly say that in their opinion it is true that 
unnecessary use of antibiotics makes them become ineffective, 10% of the respondents 




















The relationship between consumers opinion if the unnecessary use of antibiotic make 
them become ineffective and their awareness of the term Antibiotic Resistance 





Vertical axis; Awareness of the term Antibiotic Resistance (0=yes; 1=no; 2= I don’t 
know) 
Horizontal axis; Unnecessary use of antibiotics make them become ineffective (0=yes; 
1=no; 2=I don’t know) 
 
Table 8c 
Pearson Chi-Square test was conducted independently, and got a value of p=0.000, which 











Figure 17. Antibiotic Resistance awareness (n=763) 
 
Four out of five respondents (80.6%) have heard of Antibiotic Resistance, almost a 


























The relationship between the level of education and the awareness of the Antibiotic 
Resistance term 





Vertical axis; Level of education (0=Secondary level; 1=Certificate/Diploma; 
2=Bachelor’s Degree; 3=Postgraduate Degree; 4=Others) 





Pearson Chi-Square test was conducted independently, and got a value of p=0.009, which 











Figure 18. Consumers level of concern regarding antibiotic resistance (n=763) 
 
Figure 18 shows a mix of answers, 44.5% are very concerned followed by 30.4% of 

























The relationship between the level of concern regarding antibiotic resistance and the 
availability of public awareness campaigns  
 





Vertical axis; Level of concern regarding antibiotic resistance (0=very concerned;1=not 
that concerned; 2=never thought about it) 




Pearson Chi-Square test was conducted independently, and got a value of p=0.006, which 







Survey Question 15: Do you think that antibiotic resistance is a problem that you may 




Figure 19. Consumers Perception on Antibiotic Resistance Problem (n=763) 
 
 
Figure 15 shows that almost half of the respondents (41.9%) related that this is quite 
possible that they will have to deal with the antibiotic resistance problem, a third of the 
respondents say that is less likely but it is a problem for the next generation while 21% 
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Figure 20. The underlying concern associated with the antibiotic resistance (n=763) 
 
 
Figures 16 shows that half of the respondents think that the main concern associated with 
antibiotic resistance is that it may result in untreatable infections, with a higher number 
of fatalities. A quarter of the respondents think that it may result in sicker patients and 
longer hospital stays, until an effective antibiotic is given and the 21% of the respondents 
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Figure 21 presents the consumer’s level of concern about the use of antibiotics in animal 
feed. Surprisingly, a very high percentage did not think about it during their lifetime. 























Survey Question 18: Do you think that antibiotic use in food producing animals can 





Figure 22. Antibiotic use in food producing animals can indirectly affect the 
treatment of bacterial infections in humans (n=763) 
 
 
Figure 22 shows that more than half of the total respondents (64.3%) think that there is 
a relation between antibiotic use in food producing animals and the treatment of bacterial 
infections in humans. A quarter of the respondents (26.5%) were unsure about the whole 



















Relationship between Level of concern about the use of antibiotics in animal feed and 
consumers opinion if they think the use of antibiotic in food producing animal can 
indirectly affect the treatment of bacterial infections in humans 





Vertical axis; Level of concern about the use of antibiotic in animal feed (0=very concerned; 
1=not that concerned; 2= never thought about it) 





Pearson Chi-Square test was conducted independently, and got a value of p=0.000, which 




Survey Question 19: Would you choose organic meat products over conventional meat 




Figure 23. Consumers choice between organic meat products over conventional 
meat products (n=763) 
 
 
The respondents were asked if they would choose organic meat products over the 
conventional meat products if they were the same price and followed by a reason for their 
choice. The respondents were allowed to tick more than one answer. More than half of 
the respondents would choose organic meat products because they consider organic meat 
a superior product. Almost half of the respondents would choose organic meat as they are 
concerned about antibiotics use in food producing animals.  Two hundred and four 
respondents would choose organic meat for animal welfare reasons. Fifty eight responded 
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Survey Question 20: How would you prioritize the following practices to reduce 
antibiotic resistance? 





Figure 24. Practices to reduce antibiotic resistance (n=763) 
 
 
Respondents were asked to prioritize five practices to reduce antibiotic resistance from 1 
- the highest priority to 3 - the lowest priority. Each respondents had to prioritize each of 
the five practices. Following the analysis of the responses, consumers think that the 
highest priority practice is that the doctor should prescribe antibiotics only when 
absolutely necessary (562 respondents ranked this practice as highest priority), followed 
by more public awareness campaigns to explain antibiotic resistance (509 respondents 
ranked this as highest priority). Only 272 respondents chose that investing in the research 
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Survey Question 21: How would you rate the availability of public awareness 
campaigns regarding the use of antibiotics and antibiotic resistance? 
 
                                      
 
 
Figure 25. Availability of public awareness campaigns (n=763) 
 
Respondents were asked to rate the availability of public awareness campaign regarding 
the use of antibiotics and antibiotic resistance which is presented in Figure 21. Almost all 
the respondents said that the availability of public awareness campaigns is poor, 17% of 
























Survey Question 22: How would you trust to be informed about antibiotic resistance? 




                         *Others: Scientific Journals, Education, School etc. 
Figure 26. Sources of information about antibiotic resistance (n=763) 
 
Respondents were asked to give their opinion on which sources of information about 
antibiotics and antibiotic resistance are the most trustworthy.  
A large majority of respondents see social media as a source of trustworthy information 
about antibiotics followed by television.  Surprisingly, the general practitioner is not the 
top choice for the consumers.  
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CHAPTER 4: DISCUSSION 
 
This chapter discusses the data which was obtained through a suitable survey addressed 
to consumers based in Ireland. The data has been analyzed using Microsoft Excel and 
SPSS for thorough construction of charts and cross tabulations which are presented in the 
results chapter of this study.  
Reducing the overuse and misuse of antibiotics is vital to slow down and reduce 
antimicrobial resistance which has become a threat to public health in Europe and other 
parts of the world. 
The behaviour, knowledge and attitude of the public is a key factor in ensuring the prudent 
use of antimicrobials. 
 
1. Examination of antibiotic use by consumer 
 
Findings from this study show that there are variations in the use of antibiotics by the 
consumers. 
In particular, the majority of the respondents (57.3%) reported that they are trying to avoid 
taking antibiotics, unless it is absolutely necessary when treating an illness. This shows a 
certain level of awareness towards the overuse of antibiotics.  
 
2. To determine frequency of antibiotic intake 
  
Results show that 49.5% of the respondents have taken antibiotics during the last year, 
and the majority of the people surveyed take antibiotics usually once or twice a year 
(49.2%). Based on the 2018 Eurobarometer on Antibiotic Resistance, a third of Europeans 
(32%) have taken antibiotics in the last year. Across all Member States the highest 
frequency of antibiotic intake was reported in Italy (47%). The largest decrease have been 
observed in Romania (-10% versus 2016). 
  
Socio-demographic and key variable analysis: 
There are some notable differences between socio-demographic and key variable groups, 
most marked in relation to the respondents education level: Fifty seven percent of 
respondents who took antibiotics in the past year had Secondary level education, 55.7% 
Certificate/Diploma, 45.8% Postgraduate level and 45% Bachelor’s Degree. Other groups 
who are more likely to have taken antibiotics in the last year include the age group, 25% 
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age between 18-29 year old and 22% age between 30-49 year old out of the total 763 
respondents. Also, secondary level respondents had the highest frequency of antibiotic 
intake per year, 14% of respondents would take antibiotics three to four times per year. 
Another important factor contributing to appropriate antibiotic use in consumers 
understanding of when to stop taking them. WHO (2017) advised that patients should 
always take the full course of antibiotics prescribed to them by a health care professional 
because a full course is required to kill all bacteria; stopping earlier favours those strains 
that have some resistance naturally. However, our study shows that 19% of the 
respondents stop taking the antibiotic course when they feel better and think they have 
taken enough antibiotic to treat the illness. There are notable socio-demographic 
differences regarding the discontinuation of antibiotics. According to this study, 
respondents with higher level of education are more likely to take the full course of 
antibiotics. According to the data analysis, 23% of the respondents who would interrupt 
the antibiotic course when they feel better they had a Certificate/Diploma and 14% had a 
Postgraduate Degree. 
  
Understanding which conditions can be treated with antibiotics is also very important. 
Respondents were asked if they would consider taking an antibiotic for a cold or flu. The 
majority of respondents (78%) were aware that antibiotics do not treat a cold or a flu. 
According to the Eurobarometer 478 Report, published in November 2018 in 
Antimicrobial Resistance, 20% of the Europeans took antibiotics for flu and cold. There 
has been an improvement this year compared to 2016 when the percentage of Europeans 
who took antibiotics for flu and cold was 26%. 
Furthermore, respondents were asked if antibiotics are effective against viral infections. 
Almost half of the respondents correctly answered that antibiotics are not effective against 
viral infections. Data analysis encountered socio-demographic differences. Respondents 
with higher level of education (Postgraduate Degree) had a higher level of correct answers 
(58%) than lower levels of education with correct answers 39% (Secondary Level).  
 
Findings show that 82% of the respondents know that unnecessary use of antibiotics make 
them become ineffective. It is notable that 10% were unsure of the correct answer and 8% 
stated that they do not become ineffective. According to the Eurobarometer 478 Report 
(EC, 2018), most Europeans (85%) are aware that unnecessary use of antibiotics can make 
them ineffective, however respondents in Romania (74%) and Italy (70%) are least likely 




3. To determine consumers source of antibiotics 
 
It is very important to identify how respondents obtain antibiotics because tackling AMR 
involves improving prescribing practices (limiting antimicrobial medicines so that they 
are available on a prescription basis and only prescribed when needed) and stopping self-
medication.  
Findings from this study show that the vast majority of the respondents (90.2%) obtained 
their last course of antibiotics used with a medical prescription from a qualified health 
care practitioner.  
The results are quite similar with the Eurobarometer 478 (EC, 2018) on AMR results 
regarding the ways of obtaining antibiotics. The majority of Europeans obtained their last 
course of antibiotic through a healthcare professional via a medical prescription.  
 
4. To determine current awareness of antibiotic resistance 
 
The survey explored levels of awareness by asking respondents whether they had heard 
of the term Antibiotic Resistance, as it is essential that the public is aware of the 
importance of the issue of antibiotic resistance. The results show high levels of familiarity 
with the term. Overall, 80.6% of the total respondents stated they have heard the term 
Antibiotic Resistance before. The survey findings show some notable socio-demographic 
differences in relation to the awareness of the term antibiotic resistance.  
• Respondents with a higher level of education are more likely to have heard of the 
term antibiotic resistance. Following the data analysis 24% of the respondents who 
stated that they did not hear about the term antibiotic resistance were secondary level 
graduates, 21% were Certificate/Diploma graduates, 14% had a Bachelor’s Degree 
and 9% of the respondents had a Postgraduate Degree.  
• Respondents are most likely to have heard of the term if they are aged 30-49, with 
familiarity at 85%. This is significantly higher than those aged 18-29 (76%).  
The survey sought to establish the level of concern regarding antibiotic resistance. It is 
notable that 30.4% of the respondents did not express concern regarding antibiotic 
resistance and 25.1% never even thought about this issue. This is concerning, as the 
problem of antibiotic resistance requires action from everyone, from members of the 
public and policy makers, to health and agricultural professionals.  
Following the results of a multi-country public awareness survey on Antibiotic Resistance 
developed by WHO (2015), 57% of the respondents stated that There is not much people 
can do to stop antibiotic resistance, which is evidence that a more proactive approach is 
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required to improve societal understanding of antibiotic resistance including educating 
the public on step they should be taking.  
Survey respondents were also asked whether they think that antibiotic resistance is a 
problem that they might have to deal with in this lifetime. Almost half of the respondents 
(41.9%) related that it is quite possible that they will have to deal with the antibiotic 
resistance problem, while 24% stated that it might be a problem for the next generation.  
As mentioned before, Jim O’Neill published a review commissioned by the United 
Kingdom government entitled, “Antimicrobial Resistance: Tackling a crisis for the health 
and wealth of nations (the AMR Review)” and estimated that antimicrobial resistance 
could cause 10 million deaths a year by 2050. It is acknowledged that there is a large 
clinical and public health burden associated with AMR and this burden is likely to 
increase over time which requires urgent action. 
 
Respondents were given several practices which they had to prioritise to reduce antibiotic 
resistance and the top priority was “Doctor only prescribing antibiotics when absolutely 
necessary” and the least prioritised was “Investing in the research to develop new 
antibiotics to replace those that are ineffective”. This demonstrates that consumers prefer 
to prevent the issue rather than treat the problem which is a good approach. The second 
most voted statement was “More public awareness campaigns to explain antibiotic 
resistance” which would more than likely improve the lack of understanding and 
knowledge about the antibiotic resistance problem worldwide.  In addition, it suggests 
that policy makers and stakeholders have a responsibility to assist in educating the public 
regarding this problem, and the effective measures that can be taken. 
 
Respondents were asked to rate the availability of public awareness campaigns. Almost 
all the respondents stated that the availability of public awareness campaigns is poor, and 
17% of respondents rated that the availability as being none at all. Recently in Ireland, on 
November 18, the HSE launched a new campaign to raise awareness on the correct use 
of antibiotics. It is accepted in Ireland and across Europe that action needs to be taken to 
curb growing resistance to antibiotics. The key message to the campaign is – “Antibiotics 
are wasted on colds and flu”. November 18 also marked the 4th European Antibiotic 
Awareness Day, which has the aim to emphasize the importance of only taking antibiotics 
then they are really needed and encouraging the public to follow their doctor and 
pharmacists instructions on how to take antibiotics in the appropriate way. The HSE is 
working with a range of partners in Ireland and across Europe to deliver a concerted effort 
to tackle inappropriate antibiotic use. 
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It was also vital to find out how would respondents trust to be informed about antibiotic 
resistance. The majority prefers to be informed by Social Media (69.8%), followed by 
Television (65%) and GP (49.4%). There is a notable difference between the study 
findings compared to the Eurobarometer 478 on Antimicrobial Resistance where the 
respondents are most likely to view medical professional or healthcare facilities as the 
most trustworthy sources of information on antibiotics. In more general terms, it does 
elucidate the most effective methods (social media, TV etc.) to communicate important 
information regarding this issue to the public. 
 
5.  To determine consumers perception towards the association between antibiotic use in 
food producing animals and bacterial infections in humans. 
 
The survey established the level of concern regarding the use of antibiotics in animal feed. 
Half of the respondents (47%) are very concerned about the use of antibiotics in animal 
feed. Surprisingly, a very high percentage (32%) have not considered this problem to date 
and 21% were not that concerned. Data analysis showed that the majority of the 
respondents that were very concerned about the use of antibiotics in animal feed were 
also very concerned about antibiotic resistance (61.5%). Survey also shows that 39% of 
the respondents are more concerned about the use of antibiotics in animal feed rather 
(most likely from a toxicological perspective), than antibiotic resistance itself. 
 
Respondents were asked if they think antibiotic use in food producing animals can 
indirectly affect the treatment of bacterial infections in humans. More than half of the 
total respondents think that there is a relation between antibiotic use in food producing 
animals and the treatment of bacterial infections in humans. When food animals are given 
antibiotic, resistant bacteria could emerge and multiply in the intestinal tract of the animal 
the same way that can happens in people when antibiotics are used to treat infections. 
Some of these bacteria in the food animal might contaminate the surface of  meat during 
processing. If the meat is not thoroughly cooked to kill the bacteria, and enough 
organisms are present to infect a person, they could cause a food borne illness. If 
antimicrobial therapy is needed, and the causative organism are resistant, the drug may 
not be as effective in helping to cure the infection and prolonged illness could result 
(Doyle et al., 2006). Even though it is difficult for scientists to identify when this chain 
of events actually occurs, it is still considered a human food safety risk.   
The survey also investigated consumers choice between organic meat products over 
conventional meat products. Respondents could chose more than one answer. More than 
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half of the respondents (54%) would choose organic meat because they consider it a 
superior product. Almost half of the respondents (47%) would choose organic meat 
because they are concerned about antibiotics used in food producing animals, 27% of 
respondents would choose organic meat for welfare reasons and 7.6% would still prefer 



































CHAPTER 5: CONCLUSION 
 
Following the survey conducted to assess the knowledge and perception with regards to 
the use of antibiotics and AMR among the residents in Ireland, the results indicate that 
not all the respondents have  adequate information. However these findings provide valid 
elements to promote initiatives aimed at societal education regarding antibiotic use. 
Findings include specific knowledge gaps such as: antibiotics being against viruses; and 
that antibiotic treatment can end prior to course completion. It would be worthwhile for 
stakeholders and policymakers to issue guidance and assistance in addressing this 
misinformation. 
The frequency of antibiotics intake was influenced by socio-demographic parameters and 
indicates that consumers with a lower level of education had the highest intake of 
antibiotics per year. 
The study results show the diversity of public awareness regarding antibiotics and 
antimicrobial resistance on the basis of socio-demographic factors and indicated that 
consumers with lower level of education should be the main target of future educational 
campaigns. 
The study also indicates that the vast majority of the survey respondents source their 
antibiotics accordingly with a medical prescription from a qualified healthcare 
practitioner.  
According to the survey findings, respondents know there is an association between 
antibiotic use in food producing animals and bacterial infections in humans, and the 
majority of respondents would choose organic meat as it is a superior product.  
Additional didactic and systematic education campaigns regarding appropriate use are 
needed and the Social Media and television as an education tool should be considered. 
 
The European Commission has committed to continue to scale up its fight against AMR 
with the launch in June 2017 of a second action plan “A European One Health Action 
Plan against Antimicrobial Resistance (AMR)”. This new action plan will focus on 
supporting Member States, particularly in establishing, implementing and monitoring 
their national action plans. The plan will bring together EU funds and instruments in order 
to promote innovation and research in the area of AMR. The plan also aims to strengthen 





CHAPTER 6: RECOMMENDATIONS 
 
1. Government  
National, regional and local government, have the ultimately responsibility for 
developing, implementing, and supporting the policies, actions and structures necessary 
to ensure the prudent use of antibiotics. Their responsibility includes legislation, 
regulation and auditing compliance with legal, policy and professional standards.  
National strategies to combat AMR should be in line with the WHO Global Action Plan 
on AMR. 
Government strategies should include the following key elements: 
 Regulation of access and use of antibiotics. 
 Antimicrobial stewardship programmes at all levels of care (community, hospitals). 
 Qualitative and quantitative targets to improve antimicrobial prescribing. 
 Education of health professionals. 
 
2. Prescribers 
Prescribers are ultimately responsible for the decision to use antibiotics in public health 
care. Prescribers should therefore be provided with training, guidelines and information 
in order to be able to exercise prudence in the prescribing of antibiotics. 
Prescribers should include the following key elements: 
 Make a diagnosis during an in-person patient consultation before prescribing antibiotics, 
except in exceptional circumstances. 
 Ensure that appropriate microbiological samples are taken before starting antimicrobial 
treatment. 
 Avoid antibacterial treatment when there is only evidence of viral infection or of a self-
limiting bacterial infection. 
 Use antimicrobial prophylaxis only when indicated in relevant guidelines. 
 Select an antimicrobial with a spectrum of activity as narrow as possible.  
 
3. Pharmacists 
Pharmacists can act as an important source of advice and information for the public. The 
role of the pharmacist includes assessing the prescription in accordance with local policies 
for antimicrobial use; reviewing the antimicrobial duration; counselling on the use of 
restricted antimicrobials; giving advice on dosage. 
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 Only dispense antimicrobials with prescription, unless specific provisions allow for 
regulated dispensation in specific circumstances. 
 Ensure that the patients understand the dosage and duration of treatment. 
 Participate in health campaigns promoting the prudent use of antimicrobials. 
 
4. Public 
The knowledge, attitude and behavior of the public can be of profound importance in 
establishing and ensuring the prudent use of antimicrobials. Key elements for the public 
are: 
 Inform themselves and, where needed, seek information from healthcare providers about 
appropriate antimicrobial use, antimicrobial resistance and adverse reactions to 
antimicrobials. 
 Use antibiotics only when prescribed and complete the course where possible. 
 Refrain from using antimicrobials which have not been prescribed such as leftover 
antibiotics, antibiotics prescribed for another person, or antibiotics prescribed without a 
prescription. 
 
5. Professional associations and scientific societies 
 Cooperate closely with the regulatory authorities in all relevant domains to ensure that 
the proposed measures to promote the prudent use of antibiotics are evidence-based and 
feasible. 
 Promote prudent use of antibiotics through activities that include guideline development 
and training. 
 Supporting information and awareness raising activities to promote the prudent use. 
 Conduct relevant research. 
 
6. Farmers 
 Limit the prophylactic use of antimicrobials (i.e. as a preventing measure, in the absence 
of clinical signs of infection) to single animals, only when justified by a veterinarian in 
cases where there is a high risk of infection with severe consequences. 
 Metaphylaxis use (i.e. treating a group of animals when one shows signs of infection) 
should happen only where no appropriate alternative exists, and after diagnosis and 
justification from a veterinarian.  
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The development of antibiotic resistance is a globally recognised human health threat. 
Overuse and misuse of antibiotics are a major contributory factor to the development of 
antibiotic resistance. It is estimated that 10 million deaths due to AMR will occur every 
year after 2050. This equals the number of people dying of cancer every year in present 
times. 
The public plays a role in antibiotic use and the development and spread of antibiotic 
resistance. The purpose of this study was to assess the knowledge of Irish consumers 
regarding antibiotic use. In detail, it looks at the use, frequency, source and awareness of 
antibiotics and antibiotic resistance. 
A cross-sectional survey was designed to analyse consumers perception and knowledge 
on antibiotic and antibiotic resistance. It was decided on the approach of an online 
questionnaire to be circulated on multiple online platforms. 
The findings are as follows: Fifty-seven percent of respondents are trying to completely 
avoid antibiotics, unless absolutely necessary. Half of respondents took antibiotics in the 
last 12 months. The majority of respondents obtained antibiotics through a valid medical 
prescription. A prevalence of 6% of self-medication with antibiotic mainly leftovers from 
previous course was reported. Almost 80% of the respondents discontinue the antibiotic 
treatment when all antibiotics have been taken as directed. Gaps in population 
understanding of antibiotics were observed. Only 47% of the respondents knew that 
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antibiotics were not effective against viruses. Eighty-two percent of respondents 
understood that unnecessary use of antibiotics make them ineffective. Almost 16% did 
not hear of the term Antibiotic Resistance. 
It is important to note that there are some notable socio-demographic differences in 
relation to the frequency of antibiotic intake. Furthermore, this study suggests that an 
increase in educational degrees is correlated with the level of awareness Although the 
study shows a certain level of understanding of the antimicrobial resistance problem, there 




A questionnaire was developed to determine consumer’s perception on antibiotics and 
antibiotic resistance. The questionnaire consisted in 22 questions. It was decided on the 
approach of an online questionnaire to be circulated on multiple online platforms. A total 
of 763 completed questionnaires were collected. The response rate was surprisingly high 
with 600 responses recorded in 36 hours following link distribution on social media. The 
questionnaire was targeted for general public, mainly residents from Ireland. All 763 
responses were analyzed using advanced software functions of Google Forms and Excel. 
The data was further analyzed by using SPSS advanced statistical tool. The questionnaire 




A total of 763 completed questionnaires were collected. Of 763 respondents, 79.8% were 
females and 20.2% were male. When queried about their antibiotic use fifty-seven percent 
(57%) of respondents are trying to completely avoid antibiotics, unless absolutely 
necessary. Half of respondents (50%) took antibiotics in the last 12 months. Interestingly, 
a prevalence of six percent (6%) of self-medication with antibiotic mainly leftovers from 
previous course was reported. Almost eighty percent (80%) of the respondents 
discontinue the antibiotic treatment when all antibiotics have been taken as directed. Only 
forty-seven percent (47%) of the respondents knew that antibiotics were not effective 
against viruses. When asked about antibiotic resistance awareness, sixteen percent (16%) 
did not hear of the term Antibiotic Resistance. Almost all the respondents stated that the 
availability of public awareness campaigns is poor. Finally the majority of respondents, 











Following the survey conducted to assess the knowledge and perception with regards to 
the use of antibiotics and AMR among the residents in Ireland, the results indicate that 
not all the respondents have adequate information. However these findings provide valid 
elements to promote initiatives aimed at societal education regarding antibiotic use. 
Findings include specific knowledge gaps such as: antibiotics being against viruses; and 
that antibiotic treatment can end prior to course completion. It would be worthwhile for 
stakeholders and policymakers to issue guidance and assistance in addressing this 
misinformation. 
The frequency of antibiotics intake was influenced by socio-demographic parameters and 
indicates that consumers with a lower level of education had the highest intake of 
antibiotics per year. 
The study results show the diversity of public awareness regarding antibiotics and 
antimicrobial resistance on the basis of socio-demographic factors and indicated that 
consumers with lower level of education should be the main target of future educational 
campaigns. 
The study also indicates that the vast majority of the survey respondents source their 
antibiotics accordingly with a medical prescription from a qualified healthcare 
practitioner.  
According to the survey findings, respondents know there is an association between 
antibiotic use in food producing animals and bacterial infections in humans, and the 
majority of respondents would choose organic meat as it is a superior product.  
Additional didactic and systematic education campaigns regarding appropriate use are 














Appendix 1: Survey Questionnaire on Consumers Perception on Antibiotic Use and 
AMR 
 
Consumers Perception on antibiotic use and AMR 
 
1. What is your gender? 
     a) male 
     b) female 
 
2. What is your age? 
     a) 18-29 year old 
     b) 30-49 year old 
     c) 50-64 year old 
     d) 65 years or older 
 
3. What is the highest level of education you have completed? 
    a) Second level 
    b) Certificate, Diploma etc. 
    c) Bachelor’s Degree 
    d) Postgraduate qualification e.g. MSc, PhD etc  
    e) Other (Please specify) 
 
4. How would you typically treat the first symptoms of an illness? 
    a) take an antibiotic immediately to prevent onset of illness 
    b) try to manage without the antibiotic, but consider it if infection worsens 
    c) try to avoid taking antibiotics, unless absolutely necessary 
    d) use alternatives such as holistic medicine to treat illness 
    d) Others (Please specify) 
 
 
5. How often would you typically take antibiotics in a year? 
    a) Practically never 
    b) usually about once, or twice a year 
    c) usually 3 to 4 times a year 
    d) usually more often than that (>3-4 times) 
     
6. Have you taken any antibiotics in the last 12 months? 
    a) Yes 
    b) No 
    c) I don’t know 
 
7. How did you obtain the last course of antibiotics used? 
    a) got a medical prescription 
    b) old medical prescription 
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    c) somebody else’s prescription 
    d) leftover from a previous course 
    e) Other, please specify 
 
8. When do you generally stop taking antibiotics, once you commence treatment? 
   a) when you feel better and think you have taken enough antibiotic to the treat the 
illness 
   b) when you have taken all of antibiotic as directed 
   c) Other, please specify 
 
9. Would you consider taking a probiotic after an antibiotic course? 
   a) Yes 
   b) No 
   c) I don’t know 
 
10. Would you consider taking an antibiotic for a cold or flu? 
    a) Yes  
    b) No 
   c) Maybe 
 
11. In your opinion, are antibiotics effective against viral infections? 
   a) Yes 
   b) No 
   c) Sometimes 
   d) Don’t know 
 
12. In your opinion does the unnecessary use of antibiotics make them become 
ineffective? 
     a) False 
     b) True 
     c) Possibly   
     d) I don’t know 
 
13. Have you heard of the term Antibiotic resistance? 
    a) Yes 
    b) No 
    c) I don’t know 
       
14. What is your level of concern regarding antibiotic resistance? 
   a) very concerned 
   b) not that concerned 
   c) Never thought about it 
 
15. Do you think that antibiotic resistance is a problem that you may have to deal with 
in this lifetime? 
a) Yes, quite possibly 
b) No, I wouldn’t think so 
c) No, but I think it will be a problem for the next generation 
d) I don’t know 
 
16. In your opinion, what is the underlying concern associated with antibiotic 
resistance? 
     a) My antibiotic fails to work, and the doctor will need to prescribe me a new one 
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     b) I think it may result in sicker patients and longer hospital stays, until an effective 
antibiotic is   given. 
     c) I think it may result in untreatable infections, with a higher numbers of fatalities  
 
 
17. What is your level of concern about the use of antibiotics in animal feed? 
   a) very concerned 
   b) not that concerned 
   c) Never thought about it 
 
18. Do you think that antibiotics use in food producing animals can indirectly affect the 
treatment of bacterial infections in humans? 
   a) Yes  
   b) No 
   c) I don’t know 
 
19. Would you choose organic meat products over conventional meat products, if they 
were the same price? (Feel free to tick more than one answer, if preferable)  
  a) Yes, for animal welfare reasons  
  b) Yes, because I am concerned about the amount of antibiotics being used in food 
producing animals 
  c) Yes, because I would consider organic meat a superior product 
  d) No, I would select the conventional product 
  e) I don’t know 
 
20. How would you prioritise the following practices to reduce antimicrobial resistance: 
(1 the most, 5 the least) 
   a) Investing in the research to develop new antibiotics to replace those that are 
ineffective 
   b) Doctor only prescribing antibiotics when absolutely necessary 
   c) More public awareness campaigns to explain antibiotic resistance 
   d) More needs to be done to ensure that antibiotics are used appropriately in 
agriculture and only used to treat sick animals  
   e) Assisting farmers to shift methods of food production that requires less or no 
antibiotics e.g. organic farming) 
 
21. How would you rate the availability of public awareness campaigns regarding the 
use of antibiotics and antibiotic resistance? 
   a) Poor 
   b) Good 
   c) Never seen one 
 
22. How would you trust to be informed about antibiotic resistance? 
   a) GP 
   b) Radio 
   c) TV 
   d) Newspapers 
   e) Social Media 
   f) Others (Please specify) 
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